Recherche
-
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
(The Lancet. vol. 403, n° 10432, pp. 1141-1152, 2024-03-07)Article de revue -
Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis
(Journal of Clinical Medicine. vol. 11, n° 7, 2022-03-25)Article de revueLibre accès -
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources
(BMC Ophthalmol. vol. 19, n° 1, pp. 206, 2019-10-16)Article de revueLibre accès -
Standardization of optical coherence tomography angiography nomenclature in retinal vascular diseases: first survey results
(Ophthalmology Retina, 2020-12-31)Article de revueLibre accès -
Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update
(Graefe's Archive for Clinical and Experimental Ophthalmology, 2021-01-07)Article de revueLibre accès -
Mediterranean Diet and Incidence of Advanced Age-Related Macular Degeneration: The EYE-RISK Consortium
(Ophthalmology. vol. 126, n° 3, pp. 381-390, 2019-03)Article de revueLibre accès -
Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus
(Current Opinion in Ophthalmology. vol. 34, n° 5, pp. 403-413, 2023-09-01)Article de revueLibre accès -
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
(BMC Ophthalmology. vol. 20, n° 1, pp. 294, 2020)Article de revueLibre accès -
TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration
(Ophthalmology Science. vol. 1, n° 4, 2021-12)Article de revueLibre accès -
Microperimetry to predict disease progression in eyes at high risk of age-related macular degeneration disease: The PREVISION study
(Acta Ophthalmologica. vol. 101, n° 2, pp. e135-e142, 2023-03)Article de revueLibre accès